Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets

doi:10.1073/pnas.112202999

Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets

^*Research Center on Physiopathology of Hemostasis and Departments of ^¶Histology and ^‡‡Pathology, Catholic University of Rome, 00168 Rome, Italy; Departments of ^‖Hematology and ^**Histology, University of Bologna, 40126 Bologna, Italy; ^‡Department of Morphology and Embryology, University of Ferrara, 44100 Ferrara, Italy; ^††Department of Human Morphology, University of Trieste, 34138 Trieste, Italy; ^§Department of Drug Science, University of Chieti “G. D'Annunzio,” 66100 Chieti, Italy; and ^§§Department of Pharmacology, University of Rome “La Sapienza”, 00189 Rome, Italy

Communicated by Edward M. Scolnick, Merck & Co., Inc., West Point, PA (received for review December 19, 2001)

Abstract

Cyclooxygenase (COX)-1 or -2 and prostaglandin (PG) synthases catalyze the formation of various PGs and thromboxane (TX) A₂. We have investigated the expression and activity of COX-1 and -2 during human megakaryocytopoiesis. We analyzed megakaryocytes from bone marrow biopsies and derived from thrombopoietin-treated CD34⁺ hemopoietic progenitor cells in culture. Platelets were obtained from healthy donors and patients with high platelet regeneration because of immune thrombocytopenia or peripheral blood stem cell transplantation. By immunocytochemistry, COX-1 was observed in CD34⁺ cells and in megakaryocytes at each stage of maturation, whereas COX-2 was induced after 6 days of culture, and remained detectable in mature megakaryocytes. CD34⁺ cells synthesized more PGE₂ than TXB₂ (214 ± 50 vs. 30 ± 10 pg/10⁶ cells), whereas the reverse was true in mature megakaryocytes (TXB₂ 8,440 ± 2,500 vs. PGE₂ 906 ± 161 pg/10⁶ cells). By immunostaining, COX-2 was observed in <10% of circulating platelets from healthy controls, whereas up to 60% of COX-2-positive platelets were found in patients. A selective COX-2 inhibitor reduced platelet production of both PGE₂ and TXB₂ to a significantly greater extent in patients than in healthy subjects. Finally, we found that COX-2 and the inducible PGE-synthase were coexpressed in mature megakaryocytes and in platelets. We conclude that both COX-isoforms contribute to prostanoid formation during human megakaryocytopoiesis and that COX-2-derived PGE₂ and TXA₂ may play an unrecognized role in inflammatory and hemostatic responses in clinical syndromes associated with high platelet turnover.

Footnotes

↵ † To whom reprint requests should be addressed at: Centro Ricerche Fisiopatologia dell'Emostasi, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy. E-mail: b.rocca{at}tiscali.it.
Abbreviations:

PG,

prostaglandins;

COX,

cyclooxygenases;

TX,

thromboxane;

PGES,

PGE2 synthase;

iPGES,

inducible PGES;

AA,

arachidonic acid;

TPO,

thrombopoietin;

PE,

phycoerythrin